Phosphoinositide 3-kinase ? inhibitor suppresses interleukin-17 expression in a murine asthma model

Park S.J., Lee K.S., Kim S.R., Min K.H., Moon H., Lee M.H., Chung C.R., Han H.J., Puri K.D., Lee Y.C.

Source: Eur Respir J 2010; 36: 1448-1459
Journal Issue: December
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Park S.J., Lee K.S., Kim S.R., Min K.H., Moon H., Lee M.H., Chung C.R., Han H.J., Puri K.D., Lee Y.C.. Phosphoinositide 3-kinase ? inhibitor suppresses interleukin-17 expression in a murine asthma model. Eur Respir J 2010; 36: 1448-1459

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phosphoinositide 3-kinase δ inhibitor suppresses IL-17 expression in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002



The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


The effect of smoking on phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog deleted from chromosome 10 (PTEN) mRNA expression in human airway epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014


Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Phosphatidylinositol 3-kinase signaling is required for the differentiation of naive cells to CD103(αEβ7)+/CD4+-T-lymphocytes
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004

A phosphatidylinositol 3-kinase Inhibitor strongly suppressed pulmonary vascular remodeling in a murine model of allergic vasculitis
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-a and -? selectivity, suppresses COPD inflammation
Source: Eur Respir J, 50 (4) 1700188; 10.1183/13993003.00188-2017
Year: 2017



Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Pro-inflammatory role of the nuclear kinase MSK1 in asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008


LATE-BREAKING ABSTRACT: Evaluation of an oral p38 mitogen activated protein kinase (MAPK inhibitor) SB-681323 in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Inhibition of P38 kinase does not reduce production of TNF-alpha from airway cells in COPD
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Differential actions of phosphatidyinositol 3-kinase inhibitors on respiratory burst and leukotriene C4 generation in PAF-stimulated human eosinophils
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003

Ceramide-1-phosphate decreases allergic airway inflammation, remodeling and hyperresponsiveness by inhibition of phosphorilation of NF-kappa B, Akt, MAPK p-38 in dendritic cells
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


Transforming growth factor-β inhibition of lung fibroblast proliferation is mediated through prostaglandin E2, via activation of p38 mitogen-activated protein kinase
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005


Regulation of cytokine- and phorbol ester-mediated interleukin (IL)-8 expression in the absence or presence of pyocyanin in human bronchial epithelial cell line: roles of protein kinase C and mitogen-activated protein kinases
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Inhibition of p38 mitogen-activated protein kinase has no effect on macrophage phagocytosis of bacteria in patients with COPD
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013

Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway
Source: Eur Respir J 2008; 31: 523-531
Year: 2008



Inhibition of GM-CSF generation in human alveolar macrophages by reduction of histone acetylation and by dephosphorylation of p38 MAPK and MKK-1
Source: Eur Respir J 2001; 18: Suppl. 33, 475s
Year: 2001